or
forgot password
  • cancer clinical trials in minneapolis, MN

  • Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Minneapolis, Minnesota 55404
    Non Small Cell Lung Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
    Minneapolis, Minnesota 55407
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Masonic Cancer Center at University of Minnesota

    Trial Locations
    Masonic Cancer Center at University of Minnesota
    Children's Hospitals and Clinics of Minnesota - Minneapolis
    Leukemia
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Abbott-Northwestern Hospital
    Minneapolis, Minnesota 55407
    Recurrent Mantle Cell Lymphoma
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Masonic Cancer Center at University of Minnesota
    Minneapolis, Minnesota 55455
    Multiple Myeloma and Plasma Cell Neoplasm
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Hennepin County Medical Center - Minneapolis

    Trial Locations
    Hennepin County Medical Center - Minneapolis
    Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
    Masonic Cancer Center at University of Minnesota
    Breast Cancer
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    University of Minnesota Medical Center-Fairview
    Minneapolis, Minnesota 55455
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA Medical Center, Minneapolis
    Minneapolis, Minnesota 55417
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Children's Hospitals and Clinics of Minnesota - Minneapolis

    Trial Locations
    Children's Hospitals and Clinics of Minnesota - Minneapolis
    University of Minnesota Medical Center-Fairview
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Vitamin D/Calcium Polyp Prevention Study
    University of Minnesota
    Minneapolis, Minnesota 55455
    Colorectal Cancer, Polyps, Adenomas
    Post Transplant Donor Lymphocyte Infusion
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Leukemia, Myeloid, Chronic, Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, Leukemia, Lymphocytic, Acute, Leukemia, Lymphocytic, Chronic, AML
    Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Juvenile Myelomonocytic Leukemia
    Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations
    HealthPartners Research Foundation
    Minneapolis, Minnesota
    Unspecified Adult Solid Tumor, Protocol Specific
    T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome, Griscelli Syndrome, Immunologic Diseases, Langerhans-Cell Histiocytosis, Hematologic Diseases
    Stem Cell Transplant for Hemoglobinopathy
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia, Diamond-Blackfan Anemia, Shwachman-Diamond Syndrome
    Stem Cell Transplant for Immunologic or Histiocytic Disorders
    Masonic Cancer Center University of Minnesota
    Minneapolis, Minnesota 55455
    Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome, Griscelli Syndrome, Immunologic Deficiency Syndromes, Langerhans-Cell Histiocytosis
    Stem Cell Transplant w/Laronidase for Hurler
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Mucopolysaccharidosis I, Hurler Syndrome
    Stem Cell Transplant for Hematological Malignancy
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute, MDS, Leukemia, Lymphocytic, Chronic, JMML, Hodgkin's Disease, Non-hodgkin's Lymphoma, Multiple Myeloma
    Autologous Transplant for Multiple Myeloma
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Multiple Myeloma
    Alopecia Areata Registry and Immunogenetic Mechanisms
    University of Minnesota
    Minneapolis, Minnesota 55455
    Alopecia Areata
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Gastroenterology Division Veterans Affairs Medical Center
    Minneapolis, Minnesota 55417
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Minnesota Oncology Hematology, P.A.
    Minneapolis, Minnesota 55407
    Lymphoma, T-Cell, Peripheral
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Virginia Piper Cancer Institute

    Trial Locations
    Virginia Piper Cancer Institute
    Abbott-Northwestern Hospital
    Hennepin County Medical Center
    Minneapolis Veterans Medical Center
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    PhII ICb With/Without Erbitux in MBC Pts
    Minnesota Oncology Hematology, P.A.
    Minneapolis, Minnesota 55407
    Metastatic Breast Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Virginia Piper Cancer Inst
    Minneapolis, Minnesota 55407
    Non-Small Cell Lung Cancer
    Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Fanconi Anemia
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Abbott-Northwestern Hospital

    Trial Locations
    Abbott-Northwestern Hospital
    University of Minnesota Medical Center-Fairview
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Veterans Affairs Medical Center - Minneapolis
    Minneapolis, Minnesota 55417
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
    Minneapolis, Minnesota 55407
    Head and Neck Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Masonic Cancer Center at University of Minnesota

    Trial Locations
    Masonic Cancer Center at University of Minnesota
    Children's Hospitals and Clinics of Minnesota - Minneapolis
    Leukemia
    Enzastaurin Versus Lomustine in Glioblastoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Minneapolis, Minnesota 55404
    Glioblastoma
    Donor Natural Killer Cell Therapy and Aldesleukin in Treating Patients With High Risk Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
    Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455
    Acute Myelogenous Leukemia
    Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
    Masonic Cancer Center at University of Minnesota
    Minneapolis, Minnesota 55455
    Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Combination Chemotherapy With BBBD Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma
    University of Minnesota
    Minneapolis, Minnesota 55455
    Brain and Central Nervous System Tumors
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    University of Minnesota Medical Center-Fairview
    Minneapolis, Minnesota 55455
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
    University of Minnesota
    Minneapolis, Minnesota 55455
    Neurofibromatosis Type 1, Sarcoma
    Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Sirolimus, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
    Masonic Cancer Center at University of Minnesota
    Minneapolis, Minnesota 55455
    Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Masonic Cancer Center at University of Minnesota
    Minneapolis, Minnesota 55455
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Feasibility Study of Phototherapy System to Treat H Pylori
    Abbott Northwestern Hospital
    Minneapolis, Minnesota 55430
    Helicobacter Pylori
    Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic Cancer
    Masonic Cancer Center at University of Minnesota
    Minneapolis, Minnesota 55455
    Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelofibrosis, MDS, Refractory Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Hennepin County Medical Center - Minneapolis

    Trial Locations
    Hennepin County Medical Center - Minneapolis
    Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Hennepin County Medical Center

    Trial Locations
    Hennepin County Medical Center
    University of Minnesota Medical Center-Fairview
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
    Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
    Minneapolis, Minnesota 55407
    Anal Cancer
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    Univ. of Minnesota Cancer Center 420 Delaware St.

    Trial Locations
    Univ. of Minnesota Cancer Center 420 Delaware St.
    Fairview Clinical Trial Services
    Breast Cancer